HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease.The...
Inhibrx Biosciences has reported positive interim data from the Phase II segment of its HexAgon study assessing INBRX-106 in treatment-naïve,...
Partner Therapeutics has received FDA approval for Bizengri to treat adults with advanced, unresectable or metastatic cholangiocarcinoma harbouring an NRG1...
European digital health supplier Doctolib has acquired NHS GP technology supplier Medicus as part of a wider UK expansion strategy.The...
The CoMira Diagnostics JV has completed a lease agreement for its planned manufacturing facility in Sudair Industrial City, Saudi Arabia.The...
Day One Biopharmaceuticals has concluded patient enrolment in the Phase III FIREFLY-2 trial assessing tovorafenib for pLGG.The post Day One...
BMS has secured approval from the European Commission for Sotyktu (deucravacitinib) to treat active psoriatic arthritis (PsA).The post BMS’ Sotyktu...
Microsure has secured CE mark approval for its MUSA-3 system and appointed Alex Joseph as its new CEO, taking over...
MEDSIR has reported data from the PHERGain and PHERGain-2 trials, which focused on targeted therapies in early HER2-positive breast cancer.The...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.